Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    22 March 2023

    First patient dosed in second phase I clinical trial of AT278 ultra-concentrated, ultra-rapid acting insulin candidate

    Arecor Therapeutics plc, the biopharmaceutical group advancing today’s therapies to enable healthier lives, announces that the first patient has been dosed in its Phase I clinical trial investigating AT278, an ultra-rapid acting, ultra-concentrated (500 U/mL) insulin candidate, in Type ...

    22 March 2023

    Oxford Drug Design and PhoreMost collaborate to advance novel cancer therapeutics discovery

    Targeted protein degradation discovery programme to harness artificial intelligence to identify new E3 Ligase-based therapeutic strategies ...

    22 March 2023

    Bio-Rad Launches PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers

    Enhanced usability to support PCR applications in basic and translational research, process development, and quality control Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of its PTC...

    21 March 2023

    March Cresset Newsletter

    Explore the upcoming features within the upcoming Flare v7 software release, alongside a range of exciting news and updates in the Cresset March newsletter! ...

    21 March 2023

    Two leading training organisations join forces to drive brain science based leadership development for clients

    Cambridge based First Ascent Group, a leading provider of leadership development and management training programmes, has acquired The Oakridge Centre, a Manchester based company providing training, facilitation, and coaching services. ...

    21 March 2023

    Gyros Protein Technologies introduces new PurePep EasyClean services to accelerate development and manufacturing of peptide-based drugs

    Uppsala, Sweden - Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents, and a pioneer in automated nanoliter-scale immunoassays, announces the launch of three service offerings to support development and manufacturing of peptide-based drugs. The ne...

    21 March 2023

    Schoolboy to be the youngest ever competitor in 1,000km cycling race across France

    A 14-year-old schoolboy is to become the youngest ever competitor in a 1,000km ultra-endurance cycling race across France in honour of his little sister who has a brain tumour. ...

    21 March 2023

    Call for Papers: Farm to Table Sensing Technology

    Papers are invited for the Farm to Table Sensing Technology Conference: https://www.sensor100.com/SFA2023/About_SFA23.html ...

    17 March 2023

    Cancer teams at Genomics England show significant new developments in long-read sequencing

    Genomics is changing the future of healthcare – from improving diagnosis and more targeted treatments, to making healthcare systems more efficient. Using cutting-edge analytics, the cancer team at Genomics England have analysed a first batch of over 100 whole genome sequences generated...

    17 March 2023

    VetCT has extended its global operations by setting up a Canadian branch

    The new VetCT Corp. will enable the continued expansion of the global team through recruitment, while supporting the delivery of its 24/7 services. ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 212
    • Page 213
    • Current page 214
    • Page 215
    • Page 216
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS